Latest Intelligence on Healthcare in South and Central America

Published within

« | 1 | 2 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Wyeth: Big Pharma continues its shopping spree

The current economic environment has paved the way for leading pharmaceutical firms to sweep in and buy up smaller players, highlighted by Wyeth's potential acquisition of Crucell and Merck & Co's strategy to aggressively look for targets in 2009. An increasing number of pharmaceutical majors are likely to use this approach to strengthen their biologic portfolios and access novel pipeline drugs.

Published By Datamonitor
09 Jan 2009
Expert View
Expert View

The pharmaceutical industry faces unprecedented barriers to evolution

Despite the pharmaceutical industry's evolving business model in response to growing regulatory constraints, the sector is facing unprecedented challenges caused by the economic downturn and President Obama's planned overhaul of the US healthcare system. To continue on its journey towards 'Pharma 2.0', the industry must balance the more pressing short term issues against longer term trends.

Published By Datamonitor
23 Apr 2009
Expert View
Expert View

Telehealth: technology needs to meet increasing demand

Telehealth, the use of a digital network to remotely monitor and treat patients, is an emerging market with great potential to improve the quality and delivery of care and decrease healthcare costs. However, the work flow processes and technology need to improve before telehealth adoption becomes more widespread.

Published By Datamonitor
31 Aug 2007
Expert View
Expert View

Roche looks to maximize Genentech potential

Roche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, having purchased 55.9% of the company in 1990. While Genentech has historically operated independently from its parent company, it remains to be seen whether the merger will damage an operating structure which has allowed the biotech firm to drive Roche's growth performance in recent years.

Published By Datamonitor
23 Jul 2008
Expert View
Expert View

Rising healthcare costs and the economic downturn continue to shape the healthcare landscape

Aging populations, a growing prevalence of chronic diseases, and greater use of expensive treatments are among the factors putting pressure on healthcare budgets in developed and developing markets. Consequently, countries are resorting to a range of strategies including pricing and reimbursement cuts and bolstering generic uptake, in turn exerting negative pressures on pharmaceutical companies.

Published By Datamonitor
19 Apr 2011
Expert View
Expert View

Pharmacovigilance solutions: essential for the future of healthcare

Although many newer pharmacovigilance solutions are still in the nascent stages, and despite pharmaceutical companies' reluctance to adopt them, it is becoming increasingly obvious that these tools will play an essential role in protecting public health. As drug safety regulations increase, signal detection technologies will aid in the costly act of identifying and managing adverse drug events.

Published By Datamonitor
06 Jun 2008
Expert View
Expert View

Pharmaceutical product lifecycle management technology gaining momentum

Growing regulatory pressure and competition from generics will drive adoption of product lifecycle management software and services in the pharmaceutical industry. Datamonitor estimates spending on product lifecycle management software by the pharmaceutical industry in Europe, North America, China and Japan to total $460.2 million by the end of 2007 and expects this to more than double by 2012.

Published By Datamonitor
21 Sep 2007
Expert View
Expert View

Personal health records will play an important role in the exchange of health information

Early successes in healthcare interoperability are paving the way for more health information exchanges in the near to mid future. Separate networks, including personal health records, will connect to form larger networks, and despite continuing skepticism surrounding the burgeoning technology, health information exchanges look set to become a typical part of the patient experience.

Published By Datamonitor
13 Nov 2008
Expert View
Expert View

Immunization against S. aureus has potential in selected target groups

Staphylococcus aureus bacteria have become a key concern in both the hospital and community setting. The spread of resistant strains, such as MRSA, underlines the urgent need for new strategies to treat and prevent these infections. Prophylactic vaccination of target groups could be a useful tool, but prudent group selection combined with alternative prevention strategies, will be key to success.

Published By Datamonitor
17 Jul 2008
Expert View
Expert View

Google is well positioned to enter the personal health record market

Datamonitor believes that, through its brand strength, Google's entry into the personal health record market is likely to make personal health records a success and result in consumers becoming more knowledgeable about their health. While other companies have developed personal health records, the significance of Google's entry cannot be underestimated due to its unparalleled consumer reach.

Published By Datamonitor
06 Mar 2008

« | 1 | 2 | » »|

No help is available.